Back to top

Wedbush Sticks to Their Buy Rating for Revolution Medicines (RVMD)

Wedbush analyst Robert Driscoll reiterated a Buy rating on Revolution Medicines today and set a price target of $192.10. According to TipRanks, Dri...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Revolution Medicines, Inc. (RVMD)